European Multiple Sclerosis Platform

Tweet this page
<
2011
>
Registration as it was on 09 Dec 2011
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 431655212354-82

Overview

Lobbying Costs

50,000€

Financial year: Jan 2010 - Dec 2010

Lobbyists (Full time equivalent)

None declared

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Multiple Sclerosis Platform   (EMSP)

    EU Transparency Register

    44448317235-71 First registered on 09 Dec 2011

    Goals / Remit

    Exchanging and disseminating information relating to MS considering all issues relevant for people affected by MS.

    Encouraging research of all kinds that is appropriate to MS through recognised medical and other organisations.

    Promoting the development of join action programmes with the participation of national MS societies in Europe, aiming at improving the quality of their activities and services.

    Acting as a focal point for liaison with the institutions of the European Union (EU), the Council of Europe and other European organisations, in order to propose new measures to advance the rights of persons with disabilities and to ensure their full and effective participation in society.

    Main EU files targeted

    Address

    Head Office
    Auguste Lambiotte
    Brussels 1030
    BELGIUM
  • People

    Total lobbyists declared

    None declared

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    None declared

    Person with legal responsibility

    Ms Julie Deléglise (EU Affairs and Membership Officer)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2010 - Dec 2010

    Lobbying costs for closed financial year

    50,000€

    Other financial info

    Industry sponsors: Almirall, Baxter, Bayer Schering, Biogen Idec, Bioness, Genzyme, GSK (Glaxo Smith Kline), Medtronic, Merk Serono, Novartis, Pfizer

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    None declared

    Communication activities

    None declared

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard